These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 26883112)
1. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112 [TBL] [Abstract][Full Text] [Related]
2. Calprotectin and the Initiation and Progression of Head and Neck Cancer. Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623 [TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma. Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958 [TBL] [Abstract][Full Text] [Related]
4. Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma. Argyris PP; Saavedra F; Malz C; Stone IA; Wei Y; Boyle WS; Johnstone KF; Khammanivong A; Herzberg MC Oral Oncol; 2023 Feb; 137():106304. PubMed ID: 36608459 [TBL] [Abstract][Full Text] [Related]
5. Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma. Argyris PP; Slama Z; Malz C; Koutlas IG; Pakzad B; Patel K; Kademani D; Khammanivong A; Herzberg MC Oral Oncol; 2019 Aug; 95():1-10. PubMed ID: 31345374 [TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells. Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491 [TBL] [Abstract][Full Text] [Related]
7. S100A8 and S100A9 in inflammation and cancer. Gebhardt C; Németh J; Angel P; Hess J Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592 [TBL] [Abstract][Full Text] [Related]
8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304 [TBL] [Abstract][Full Text] [Related]
9. S100A9 has a protective role in inflammation-induced skin carcinogenesis. McNeill E; Hogg N Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096 [TBL] [Abstract][Full Text] [Related]
10. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo. Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301 [TBL] [Abstract][Full Text] [Related]
11. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products. Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984 [TBL] [Abstract][Full Text] [Related]
12. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH. Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783 [TBL] [Abstract][Full Text] [Related]
13. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE. Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757 [TBL] [Abstract][Full Text] [Related]
14. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas. Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368 [TBL] [Abstract][Full Text] [Related]
15. Expression and function of S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella model. De Jong HK; Achouiti A; Koh GC; Parry CM; Baker S; Faiz MA; van Dissel JT; Vollaard AM; van Leeuwen EM; Roelofs JJ; de Vos AF; Roth J; van der Poll T; Vogl T; Wiersinga WJ PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003663. PubMed ID: 25860480 [TBL] [Abstract][Full Text] [Related]
17. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma. Funk S; Mark R; Bayo P; Flechtenmacher C; Grabe N; Angel P; Plinkert PK; Hess J Int J Cancer; 2015 May; 136(9):2037-46. PubMed ID: 25302747 [TBL] [Abstract][Full Text] [Related]
18. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells. Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061 [TBL] [Abstract][Full Text] [Related]
19. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma. Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444 [TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 activate key genes and pathways in colon tumor progression. Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]